Healthcare Market Research Worldwide

SyndiTrack™

Accelerate Your Decisions With Ready-made Market Intelligence.

Our SyndiTrack™ solution provides robust, multi-country data without the wait or setup. Flexible, cost-effective, and fully compliant. Get insights fast, and act even faster.

Fast Access to Insights
Many datasets are already available or ready to launch. No long setup phase needed.
Tailored Flexibility
Choose your modules, countries, or respondent types. You can even request custom add-ons or analyses to fit your needs.
Broad Geographic Coverage
Available in up to 45 countries. Ideal for regional or global benchmarking.
Easy Compliance
With no pharmacovigilance obligations, access to data is simple and fast.
Cost-Effective
Benefit from pooled resources without compromising data quality or strategic value.
Ideal For
  • Competitive intelligence and brand tracking
  • Rapid market scoping
  • Benchmarking treatment patterns across countries
  • Identifying emerging trends and unmet needs

Let's Talk

Éric Yönter
Partnership Strategy Director
Paul Taylor
Partnership Strategy Director
Back

Éric Yönter

Partnership Strategy Director

Eric has joined APLUSA after over 20 years dedicated at growing exceptional relationships with clients in the pharmaceutical industry across Europe and Asia. Eric brings in a solid expertise in the sale of services (market research studies, databases, panels of physicians and pharmacies) to help implementing, together with our Business Unit Directors and experts, commercial partnerships that will match even more our clients’ expectations.

Graduate of the Ecole Supérieure de Gestion (now Paris School of Business), Eric also holds a master’s degree in economic and social administration from the University of Paris-Assas and an Executive MBA in healthcare management from the University of Paris-Dauphine.

Back

Paul Taylor

Partnership Strategy Director

Paul has been working in international healthcare market research for over 20 years, and is based in our London office. Paul is responsible for supporting global and UK-based clients with their needs across all therapy areas and methodologies. Paul enjoys studies that include patients, as well as those relating to medical devices, and spent numerous years working with longitudinal data from hospital records in Europe.

Paul has previously worked with Aequus Research, Medimix and IQVIA, successfully developing new business among pharmaceutical and Biotech clients in Europe, Japan, Latin America and the USA. Paul has a wealth of experience within various therapeutic classes, noticeably in Oncology and Multiple Sclerosis as well as Diabetes, Epilepsy, HIV, pain management and Anti-Infectives.